PROCESS FOR PRODUCING BILOGICALLY ACTIVE PROTEIN-GANGLIOSIDE COMPLEX COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENT

• 1. 叶酸－多聚糖复合物，其制备方法和以该复合物为活性成分的药物组合物 [P] . 中国专利： CN1095472C . 2002.12.04
• 2. 叶酸－多聚糖复合物,其制备方法和以该复合物为活性成分的药物组合物 [P] . 中国专利： CN1287127A . 2001-03-14
• 3. PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING ORGANIC PLATINUM COMPLEX AS ACTIVE INGREDIENT AND FOR PRODUCING THE ACTIVE INGREDIENT [P] . HU198731B . 1989-11-28

  机译： 制备包含有机铂络合物作为活性成分的药物成分的方法以及用于生产活性成分的方法

• 4. PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING ORGANIC PLATINUM COMPLEX AS ACTIVE INGREDIENT AND THE ACTIVE INGREDIENTS [P] . HUT47124A . 1989-01-30

  机译： 包含有机铂化合物作为活性成分和活性成分的药物成分的制备方法

• 5. PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING HETERCYCLIC COMPOUNDS AS ACTIVE INGREDIENT AND PROCESS FOR PRODUICNG THE ACTIVE INGREDIENTS [P] . HUT59125A . 1992-04-28

  机译： 包含作为活性成分的杂环化合物的药物组合物的制备方法和活性成分的制备方法

• 1. Simultaneous and Trace Level Quantification of Five Potential Genotoxic Impurities in Ranolazine Active Pharmaceutical Ingredient Using LC-MS/MS [J] . Kartheek Srinivas Chidella, Vijaya Bharathi Dasari, Jayashree Anireddy 美国分析化学（英文） . 2021,第001期
• 2. Development of a rapid GC-FID method to simultaneously determine triethylamine,diisopropylamine,and 1,1,3,3-tetramethylguanidine residues in an active pharmaceutical ingredient [J] . Minshan Shou, Haixiao Qiu 药物分析学报（英文） . 2021,第002期
• 3. Multiple Emulsions Able to Be Used for Oral Administration of Active Pharmaceutical Ingredients: Physico-Chemical Parameters Study of Different Phases [J] . Louis Augustin Diaga Diouf, Alphonse Rodrigue Djiboune, Mamadou Soumboundou, 现代物理（英文） . 2020,第010期
• 4. Data Validation and Modelling of Thermodynamic Properties of Systems with Active Pharmaceutical Ingredients (APIs) in Complex Media for Skin Absorption Processes [C] . Lukasz Ruszczynski, Alexandr Zubov, Gilrkan Sin European Symposium on Computer Aided Process Engineering . 2017
• 5. Photodegradation of selected endocrine and pharmaceutically active compounds under environmentally relevant conditions -- Processes and products. [D] . Young, Robert B. 2014
• 6. The Stereoselective Nitro-Mannich Reaction in the Synthesis of Active Pharmaceutical Ingredients and Other Biologically Active Compounds [O] . Ana Maria Faisca Phillips, M. Fátima C. Guedes da Silva, Armando J. L. Pombeiro 2020
• 7. Compositional effect of complex biorelevant media on the crystallization kinetics of an active pharmaceutical ingredient [O] . Jennifer Lu, James D. Ormes, Michael Lowinger, 2017

• 1. Identification,synthesis and characterization of an unknown process related impurity in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS,~1H,^(13)C and ~1H-~1H COSY NMR [J] . Saji Thomas ,Saroj Kumar Paul ,Subhash Chandra Joshi . 药物分析学报：英文版 . 2014,第5期
• 2. Simultaneous Determination of N-Acetyl Cysteine and Taurine by HPTLC Method in Active Pharmaceutical Ingredient and Pharmaceutical Dosage Form [J] . A. R. Magesh ,Magharla Dasaratha Dhanaraju . 美国分析化学（英文） . 2017,第11期
• 3. 由天然产物获取具有生物活性的先导化合物＊传统方法与三维结构检索方法的比较 [C] . . 中国化工学会农药专业委员会第九届年会 . 1998
• 4. 具有生物活性的新型含氮杂环化合物的研究——HPPD抑制剂和含吡啶的喹唑啉酮类化合物的合成、结构鉴定及生物活性研究 [A] . 罗铁军 . 2002